CLINICAL_TRIALS
withdrawal
· 2020-11-16
Clinical Trial Update: The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder [Phase 3]
Summary
Phase 3 trial on anticonvulsants for alcohol dependence with PTSD has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yale University | Conditions: Alcohol Dependence, Post Traumatic Stress Disorder | Phase 3 | Status: WITHDRAWN